Alteration of Polypeptide Backbone Structure as determined by Circular Dichroic Spectral Analysis in Relation to Change of Plasminogen Activator Activity of Two Forms of Human Urinary Urokinase denatured with Guanidine Hydrochloride

スポンサーリンク

概要

• 論文の詳細を見る

• Alterations of polypeptide backbone structure and plasminogen activator activity of human urinary urokinase (UK) denatured with 0-6 M guanidine hydrochloride (Gdn-HCl) were investigated. The fractions of helix, β-from, β-turn and unordered structure were determined by the best-curve-fitting method based on the circular dichroic (CD) spectra at 200-240 nm to be 0.14,0.23,0.26 and 0.37 for M.W. 55000 form (H-UK) and 0.12,0.17,0.32 and 0.40 for M.W. 36000 form (L-UK), respectively. In view of the variation with Gdn-HCl concentration of ellipticity at the negative extrema (204 nm for H-UK ; 202 nm for L-UK), the denaturation process was concluded not to be a two-state transition : at 2.0-3.0M Gdn-HCl, the helical and β-form fractions were immobilized within a narrow range of 0.00-0.01 for both UK forms, corresponding to almost unchanged minimal ellipticities even with the increase of Gdn-HCl concentration. This indicates that an intermediate state (I) exists besides the native (N) and denatured (D) states. At 0.75-1.25 M Gdn-HCl, an activated state (A) intervened between N and I for H-UK but not for L-UK. The N→A transition of H-UK was an exceptional transition in that the helicity steadily increased with the enhanced minimal ellipticity. This corresponded to the observation that the activity of H-UK was potentiated by 18% during this transition. At the same Gdn-HCl concentration, L-UK reduced both its activity by 27-38% and its minimal ellipticity in contrast to H-UK. These findings show that the denaturation processes consist of "four states-three transitions" for H-UK and "three states-two transitions" for L-UK.

• 公益社団法人日本薬学会の論文
• 1982-10-25

著者

• 鈴木 章

  Traditional Chinese Medicine Research Laboratory Kanebo Co. Ltd.

• 山下 明

  鐘紡

• 三羽 信比古

  Pharmaceuticals Research Center Kanebo Ltd.

• 鈴木 章

  Pharmaceuticals Research Center, Kanebo, Ltd.

• 山下 明

  Pharmaceuticals Research Center, Kanebo, Ltd.

• 山下 明

  Pharmaceuticals Research Center Kanebo Ltd.

関連論文

• Determination of Particle Size Distribution of Fluorocarbon Emulsion by Means of Centrifugal Sedimentation : A Proposal for Specifying the Particle Size Distribution
• Isoelectric Points of Two Molecular Forms of Human Urinary Urokinase determined by Density-gradient Isoelectric Focusing and Isotachoelectrophoresis
• Alteration of Polypeptide Backbone Structure as determined by Circular Dichroic Spectral Analysis in Relation to Change of Plasminogen Activator Activity of Two Forms of Human Urinary Urokinase denatured with Guanidine Hydrochloride
• Comparative Studies on Two Active Enzyme Forms of Human Urinary Urokinase. II. pH- and Heat-stabilities of Plasminogen Activator Activity
• Comparative Studies on Two Active Enzyme Forms of Human Urinary Urokinase. I. Purification by Serial Column Chromatography and Homogeneity Analyses of Molecular Weight and Isoelectric Point
• Identification of Tissues Responsible for the Conjugative Metabolism of Liquiritigenin in Rats : An Analysis Based on Metabolite Kinetics
• Studies on Powdered Preparations. XVIII. Dissolution Rate of Sulfadiazine in Various Aqueous Solutions.
• Studies on Powdered Preparations. XVII. Dissolution Rate of Sulfonamides by Rotating Disk Method
• Studies on Powdered Preparations. XIII. Reaction between Dried Aluminum Hydroxide Gel and Organic Acid

スポンサーリンク